Dalton, Greiner, Hartman, Maher & Co’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
Other funds holding HCA
Dalton, Greiner, Hartman, Maher & Co's HCA Position: Q2 2021 in Review
Dalton, Greiner, Hartman, Maher & Co sold out of HCA Healthcare (HCA) in Q2 2021, closing a stake of 7,805 shares — an estimated $1.47M sold.
Dalton, Greiner, Hartman, Maher & Co first reported a position in HCA in Q3 2020 and held it in 3 quarters. The position peaked at $2.05M in Q4 2020. 823 funds tracked by Wall St. Rank hold HCA as of Q2 2021.
- Dalton, Greiner, Hartman, Maher & Co reported no remaining HCA Healthcare position as of Q2 2021 after selling out during the quarter.
- Dalton, Greiner, Hartman, Maher & Co sold 7,805 HCA Healthcare shares in Q2 2021, an estimated $1.47M.
- Dalton, Greiner, Hartman, Maher & Co first reported a position in HCA Healthcare in Q3 2020 and held it in 3 quarters.
- Dalton, Greiner, Hartman, Maher & Co's HCA Healthcare position peaked at $2.05M in Q4 2020.
- 823 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2021.
Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q2 2021.